For help on how to get the results you want, see our search tips.
23 results
Categories
Human Remove Human filter
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Tecfidera (updated)
dimethyl fumarate, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Steglatro
ertugliflozin, opinion date: 16/09/2021, Positive, Last updated: 30/09/2021 -
List item
Summary of opinion: Galvus
vildagliptin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Elebrato Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Temybric Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Rapiscan
regadenoson, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Siklos
hydroxycarbamide, opinion date: 22/07/2021, Negative, Last updated: 23/07/2021 -
List item
Summary of opinion: Senshio
ospemifene, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Segluromet
ertugliflozin, metformin hydrochloride, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
vildagliptin, metformin, opinion date: 21/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Cabometyx
cabozantinib, opinion date: 24/03/2022, Positive, Last updated: 25/03/2022 -
List item
Summary of opinion: Polivy
polatuzumab vedotin, opinion date: 24/03/2022, Positive, Last updated: 25/03/2022 -
List item
Summary of opinion: Beovu
brolucizumab, opinion date: 24/02/2022, Positive, Last updated: 25/02/2022 -
List item
Summary of opinion: Elonva (new)
corifollitropin alfa, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Yescarta (new)
axicabtagene ciloleucel, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: NovoSeven (new)
eptacog alfa (activated), opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Bydureon (new)
exenatide, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Retsevmo (new)
selpercatinib, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Opdivo
nivolumab, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Tecentriq (new)
atezolizumab, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Vimpat
lacosamide, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Keytruda (new)
pembrolizumab, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022